Home / Inspections / 920771

FDA Inspection 920771 — Abbas Ardehali, MD

Abbas Ardehali, MD — FEI 3011447384

The FDA completed an inspection of Abbas Ardehali, MD on April 2, 2015 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 2, 2015
Fiscal Year
2015
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Los Angeles, CA (United States)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources